Morgens Waterfall Vintiadis & Co’s Teladoc Health TDOC Stock Holding History

Morgens Waterfall Vintiadis & Co’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7,800	Closed	-$1.42M	–	39
2021 Q1	$1.42M	Sell	7,800 -2,200	-22%	-$510K	0.79%	32
2020 Q4	$2M	Sell	10,000 -2,400	-19%	-$488K	1.08%	24
2020 Q3	$2.72M	Sell	12,400 -600	-5%	-$127K	1.55%	25
2020 Q2	$2.48M	Buy	13,000 +3,000	+30%	+$526K	1.59%	26
2020 Q1	$1.55M	Buy	+10,000	New	+$1.16M	1.45%	25
2018 Q4	–	Sell	-45,000	Closed	-$3.89M	–	69
2018 Q3	$3.89M	Sell	45,000 -15,000	-25%	-$1.07M	2.54%	13
2018 Q2	$3.48M	Hold	60,000	–	–	2.47%	18
2018 Q1	$2.42M	Hold	60,000	–	–	1.84%	22
2017 Q4	$2.09M	Buy	60,000 +20,000	+50%	+$664K	1.65%	23
2017 Q3	$1.33M	Buy	40,000 +19,400	+94%	+$636K	1.11%	30
2017 Q2	$715K	Sell	20,600 -9,400	-31%	-$274K	0.69%	43
2017 Q1	$750K	Buy	+30,000	New	+$624K	0.66%	43

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgens Waterfall Vintiadis & Co's TDOC Position: Q2 2021 in Review

Morgens Waterfall Vintiadis & Co sold out of Teladoc Health (TDOC) in Q2 2021, closing a stake of 7,800 shares — an estimated $1.42M sold.

Morgens Waterfall Vintiadis & Co first reported a position in TDOC in Q1 2017 and held it in 12 quarters. The position peaked at $3.89M in Q3 2018. 829 funds tracked by Wall St. Rank hold TDOC as of Q2 2021.

Morgens Waterfall Vintiadis & Co reported no remaining Teladoc Health position as of Q2 2021 after selling out during the quarter.
Morgens Waterfall Vintiadis & Co sold 7,800 Teladoc Health shares in Q2 2021, an estimated $1.42M.
Morgens Waterfall Vintiadis & Co first reported a position in Teladoc Health in Q1 2017 and held it in 12 quarters.
Morgens Waterfall Vintiadis & Co's Teladoc Health position peaked at $3.89M in Q3 2018.
829 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2021.

Based on Morgens Waterfall Vintiadis & Co's 13F filing for Q2 2021, filed 16 Aug 2021.